The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Discover the FDA-approved indications for GLP-1 receptors, including diabetes, weight loss, and cardiovascular disease. Learn brand-name and generic options.

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia University have created an artificial intelligence model that can predict which ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

"A world in which human wages crash from AI — logically ... everyone's economic suffering in the interim merely a means to an end. Like overzealous fitness instructors, they always choose ...

This important study assessed the effects of food intake on sharp wave-ripples in the hippocampus of mice during subsequent sleep. Solid evidence supports the conclusion that sharp wave-ripples are ...

Jan. 24, 2025 — A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to ...